Package Leaflet: Information for the Patient
Perindopril/Amlodipine/Indapamide Krka7 mg/5 mg/2.5 mg film-coated tablets EFG
perindopril arginine/amlodipine/indapamide
Read the entire package leaflet carefully before starting to take this medicine, as it contains important information for you.
Contents of the Package Leaflet
Perindopril/Amlodipine/Indapamide Krka is a combination of three active substances: perindopril, amlodipine, and indapamide.
Perindopril/amlodipine/indapamide is an antihypertensive medicine used to treat high blood pressure in adults.
Patients who are already taking perindopril/amlodipine as a fixed-dose combination and indapamide in separate tablets may take instead one tablet of Perindopril/Amlodipine/Indapamide Krka containing the three active substances at the same doses.
Each of the active substances lowers blood pressure, and they all work together to control your blood pressure:
Do not take Perindopril/Amlodipine/Indapamide Krka
Warnings and precautions
Consult your doctor or pharmacist before starting to take Perindopril/Amlodipine/Indapamide:
Your doctor may monitor your kidney function, blood pressure, and the amount of electrolytes (such as potassium) in your blood periodically. See also the information under the heading "Do not take Perindopril/Amlodipine/Indapamide Krka".
Angioedema:
In patients treated with ACE inhibitors, including perindopril, angioedema (a severe allergic reaction with swelling of the face, lips, tongue, or throat with difficulty swallowing or breathing) has been reported. This can occur at any time during treatment. If you develop these symptoms, you should stop taking Perindopril/Amlodipine/Indapamide and see a doctor immediately. See also section 4.
You should inform your doctor if you think you are (or might become) pregnant. Perindopril/amlodipine/indapamide is not recommended at the start of pregnancy, and should not be taken after the third month of pregnancy, as it may cause serious harm to your baby if used after the third month of pregnancy.
When taking perindopril/amlodipine/indapamide, you should inform your doctor or healthcare professional if you:
Your doctor may recommend that you have blood tests to check for low sodium or potassium levels or high calcium levels.
Athletes should be aware that Perindopril/Amlodipine/Indapamide contains an active substance (indapamide) that may give a positive result in a doping test.
Children and adolescents
Perindopril/amlodipine/indapamide should not be given to children or adolescents.
Other medicines and Perindopril/Amlodipine/Indapamide Krka
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
You should avoid taking Perindopril/Amlodipine/Indapamide with:
Treatment with perindopril/amlodipine/indapamide may be affected by other medicines. Make sure to inform your doctor if you are taking any of the following medicines, as you may need special care:
Taking Perindopril/Amlodipine/Indapamide Krka with food and drinks
See section 3.
People taking perindopril/amlodipine/indapamide should not consume grapefruit juice or grapefruit. This is because grapefruit and grapefruit juice can lead to an increase in the levels of the active ingredient amlodipine in the blood, which can cause an unpredictable increase in the blood pressure-lowering effect of this medicine.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
You should inform your doctor if you think you are (or might become) pregnant.
Your doctor will normally advise you to stop taking this medicine before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of perindopril/amlodipine/indapamide. This medicine is not recommended during the first trimester of pregnancy, and should not be taken after the third month of pregnancy, as it may cause serious harm to your baby if used after the third month of pregnancy.
Breastfeeding
Amlodipine has been shown to pass into breast milk in small amounts. Inform your doctor if you are breastfeeding or plan to breastfeed. Perindopril/amlodipine/indapamide is not recommended for breastfeeding mothers, and your doctor may choose another treatment for you if you want to breastfeed your baby, especially if your baby is newborn or premature.
Driving and using machines
Perindopril/Amlodipine/Indapamide may affect your ability to drive or use machines. If the tablets make you feel sick, dizzy, weak, or tired, or give you a headache, do not drive or use machinery and consult your doctor immediately.
Perindopril/Amlodipine/Indapamide Krka contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per dose; this is essentially "sodium-free".
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is one Perindopril/Amlodipine/Indapamide tablet once a day.
Take the tablet preferably at the same time each day, in the morning and before breakfast.
Do not exceed the prescribed dose.
If you take more Perindopril/Amlodipine/Indapamide Krka than you should
If you take too many tablets, contact your doctor or go to the emergency department of your nearest hospital immediately.
The most frequent symptom in case of overdose is a decrease in blood pressure that can cause dizziness or fainting. If this occurs, it may help to lie down with your legs raised.
It can cause nausea (feeling of dizziness), vomiting, cramps, drowsiness, confusion, and changes in the amount of urine produced by the kidneys.
You may feel dizzy, lightheaded, or weak. If the drop in your blood pressure is severe enough, you may suffer from shock. You may feel your skin cold and wet, and you may lose consciousness.
Excess fluid may accumulate in the lungs (pulmonary edema) causing difficulty breathing, which can develop up to 24-48 hours after ingestion.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Perindopril/Amlodipine/Indapamide Krka
It is essential to take this medication every day, as continuous treatment works better. However, if you forget to take a dose of perindopril/amlodipine/indapamide, take the next dose at the usual time. Do not take a double dose to make up for the missed doses.
If you stop treatment with Perindopril/Amlodipine/Indapamide Krka
Since treatment with perindopril/amlodipine/indapamide is usually for life, you should talk to your doctor before stopping this medication.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Stop treatment with this medication and go to your doctor immediately if you experience any of the following side effects that can be serious:
In decreasing order of frequency, side effects may include:
Very common (may affect more than 1 in 10 people):
Edema (fluid retention).
Common (may affect up to 1 in 10 people):
Low potassium levels in the blood, headache, numbness or tingling in the extremities, drowsiness (especially at the beginning of treatment), changes in taste, changes in vision (including double vision), tinnitus (ringing in the ears), vertigo, palpitations (feeling the heartbeat), flushing, dizziness, cough, difficulty breathing (dyspnea), abdominal pain, constipation, diarrhea, dyspepsia, or difficulty digesting, nausea, vomiting, changes in bowel habits, itching, allergic reactions such as skin rashes, itching, redness of the skin, muscle cramps, swelling of the ankles (edema), feeling of fatigue, weakness.
Uncommon (may affect up to 1 in 100 people):
Rhinitis (congested or runny nose), increased number of certain white blood cells (eosinophilia), low blood sugar levels (hypoglycemia), high potassium levels in the blood that can cause an abnormal heartbeat (hyperkalemia), low sodium levels in the blood (hyponatremia) that can cause dehydration and low blood pressure, insomnia, mood changes, anxiety, depression, sleep disorders, loss of pain sensation, tremors, fainting, vasculitis (inflammation of blood vessels), dry mouth, hair loss, red spots on the skin (purpura), skin discoloration, increased sweating, photosensitivity reaction (changes in skin appearance) after exposure to sun or artificial UVA rays, formation of blisters on the skin, muscle or joint pain, back pain, urination disorders, increased need to urinate at night, increased frequency of urination, kidney problems, impotence (inability to have or maintain an erection), discomfort or enlargement of the breasts in men, chest pain, pain, feeling of discomfort, fever, increased urea in the blood, increased creatinine in the blood, fall.
Rare (may affect up to 1 in 1,000 people):
Low chloride levels in the blood, low magnesium levels in the blood, confusion, worsening of psoriasis, high bilirubin levels in the blood, increased liver enzyme levels, decreased or absent diuresis, acute kidney failure.
Concentrated urine, feeling of discomfort (nausea) or being sick (vomiting), muscle cramps, confusion, and convulsions. These symptoms can be from a disease called SIADH (inadequate secretion of antidiuretic hormone).
Very rare (may affect up to 1 in 10,000 people):
Changes in blood parameters such as decreased number of white and red blood cells, decreased hemoglobin concentration, decreased platelet count, high blood sugar levels (hyperglycemia), high calcium levels in the blood (hypercalcemia), increased muscle tension, nerve disorder that can cause weakness, eosinophilic pneumonia (a rare type of pneumonia), gum inflammation, abdominal swelling (gastritis), yellowing of the skin (jaundice), acute kidney failure.
Frequency not known (cannot be estimated from available data):
Short-sightedness (myopia), blurred vision, decreased vision, or eye pain due to high pressure (possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma), if you suffer from systemic lupus erythematosus (a type of collagen disease) it could worsen, abnormal electrocardiogram, tremors, postural rigidity, facial rigidity similar to a mask, slow movements, and imbalance in gait with foot dragging, increased uric acid, a substance that can cause or worsen gout (pain in the joints, especially in the feet), color change, numbness, and pain in the fingers of the hands or feet (Raynaud's disease).
If you have these symptoms, contact your doctor as soon as possible.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System for Human Use: www.notificaram.es.
By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date that appears on the box and blister pack after "EXP". The expiration date is the last day of the month indicated.
This medication does not require any special storage temperature.
Keep it in the original packaging to protect it from light and moisture.
Medications should not be thrown down the drain or into the trash. Deposit the packaging and medications you no longer need at the SIGRE collection point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Composition of Perindopril/Amlodipine/Indapamide Krka
Appearance of the product and package contents
The Perindopril/Amlodipine/Indapamide Krka tablets are white or almost white, round (8 mm in diameter), biconvex, marked with K4 on one side.
The Perindopril/Amlodipine/Indapamide Krka tablets are available in packs of 10, 30, 60, 90, 100, or 120 tablets, in a box.
Only some pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
KRKA, d.d., Novo mesto,
Šmarješka cesta 6,
8501 Novo mesto,
Slovenia
Manufacturer
KRKA, d.d., Novo mesto,
Šmarješka cesta 6,
8501 Novo mesto,
Slovenia
Or
TAD PHARMA GMBH
Heinz Lohmann strasse, 5
D-27472 Groden Cuxhaven
Germany
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
KRKA Farmacéutica, S.L.,
Calle de Anabel Segura 10,
28108 Alcobendas, Madrid,
Spain
This medication is authorized in the member states of the European Economic Area with the following names:
Member state | Medication name |
Germany | Co-Amlessa 7 mg/5 mg/2.5 mg tablets |
Cyprus | CO-APERNEVA 7 mg/5 mg/2.5 mg tablets |
Slovenia | Argininijev perindoprilat/indapamid/amlodipin Krka 7 mg/5 mg/2.5 mg tablets |
Spain | Perindopril/Amlodipine/Indapamide Krka 7 mg/5 mg/2.5 mg tablets EFG |
Ireland | Dalnecombi 7 mg/5 mg/2.5 mg tablets |
Latvia | Perindopril arginine/Amlodipine/Indapamide TAD 7 mg/5 mg/2.5 mg tablets |
Lithuania | Perindopril arginine/amlodipine/indapamide Krka 7 mg/5 mg/2.5 mg tablets |
Poland | COARAMLESSA |
Date of the last revision of this leaflet: January 2025
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).